• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Educational Intervention Reduces Utilization of Low-Value Testing in Cerebrovascular Inpatients: An Example of Rapidly Implementable Quality Improvement (P2.309)
Conclusions: In this prospective quality improvement study, an educational intervention resulted in significant reduction in utilization of low-value tests in patients admitted to an inpatient cerebrovascular service. While the per-patient costs of these diagnostic tests were small, a similar approach at the system level could result in considerable avoidance of low value testing and associated costs, particularly if applied to higher-cost/lower-value investigations and procedures.Disclosure: Dr. Scharf has nothing to disclose. Dr. Jones has nothing to disclose. Dr. Martinez-Thompson has nothing to disclose. Dr. Pichler ha...
Source: Neurology - April 3, 2016 Category: Neurology Authors: Scharf, E., Jones, A., Martinez-Thompson, J., Pichler, M., Cohen, A., Clark, S., Nozile-Firth, K., Jones, L. Tags: Stroke Systems of Care Source Type: research

The Speed and Reliability of Pre-Hospital Point-of-Care Laboratory Testing on the Mobile Stroke Treatment Unit (P4.314)
Conclusion: Critical laboratory tests can be performed rapidly and successfully in a MSTU to assist in early pre-hospital ischemic stroke thrombolysis or warfarin reversal in ICH.Disclosure: Dr. Organek has nothing to disclose. Dr. Taqui has nothing to disclose. Dr. Cerejo has nothing to disclose. Dr. Itrat has nothing to disclose. Dr. Buletko has nothing to disclose. Dr. Cho has nothing to disclose. Dr. Sheikhi has nothing to disclose. Dr. Winners has nothing to disclose. Dr. Rasmussen has nothing to disclose. Dr. Hussain has nothing to disclose. Dr. Uchino has nothing to disclose.
Source: Neurology - April 8, 2015 Category: Neurology Authors: Organek, N., Taqui, A., Cerejo, R., Itrat, A., Buletko, A., Cho, S., Sheikhi, L., Winners, S., Rasmussen, P., Hussain, M., Uchino, K. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke, Prehospital, and Telemedicine Source Type: research

Recurrent right middle cerebral artery territory infarctions in a patient with JAK2 (V617F) point mutation positive polycythemia rubra vera (P2.258)
CONCLUSIONS: Hyperviscosity in polycythemia with hematocrit of more than 43[percnt] is known to cause ischemic events and it is evident in our case where our patient had recurrent ischemic strokes whenever the HCT is about 50[percnt] and the right MCA M1 segment though a mild stenosis, it becomes a critical factor for this patient as the patient had recurrent right MCA territory infarcts and hence in addition to regular phlebotomy to keep hematocrit less than 43[percnt], our patient might also need intervention in the form of cerebral angioplasty or stenting to treat even mild arterial stenosis. Study Supported by: ...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Suri Mohanram, S., Nattanmai Chandrasekaran, P. Tags: Cerebrovascular Disease and Interventional Neurology: Genetics and Stroke Source Type: research